Clinically isolated syndrome (CIS) is an episode of neurologic symptoms that lasts at least 24 hours and can’t be associated with fever, infection, or other illness.
CIS, by its very name, indicates that you’ve had an isolated incident. It doesn’t mean you should expect more or that you’ll definitely develop multiple sclerosis (MS). However, CIS is sometimes the first clinical episode of MS and is often categorized as a type of MS.
Continue reading to learn more about the connection between CIS and MS, how the distinction is made, and what your next steps should be.
The big difference between CIS and MS is that CIS is a single episode while MS involves multiple episodes, or flare-ups.
With CIS, you don’t know if it will ever happen again. Conversely, MS is a lifelong disease without a cure, though it can be managed.
Some conditions and symptoms associated with CIS include:
- Optic neuritis. In this condition, your optic nerve is damaged. This can cause poor vision, blind spots, and double vision. You might also experience eye pain.
- Transverse myelitis. This condition involves damage to your spinal cord. Symptoms can include muscle weakness, numbness and tingling, or bladder and bowel issues.
- Lhermitte’s sign. Also known as the barber chair phenomenon, this sensation is caused by a lesion on the upper part of your spinal cord. An electric shock-like feeling goes from the back of your neck to your spinal column. This may happen when you bend your neck downward.
CIS can cause difficulties with:
- balance and coordination
- dizziness and shakiness
- muscle stiffness or spasticity
- sexual function
Both CIS and MS involve damage to the myelin sheath. Inflammation causes lesions to form, which interrupt signals between your brain and the rest of the body.
Symptoms depend on the location of the lesions. They can range from barely detectable to disabling. It’s hard to distinguish CIS from MS based on symptoms alone.
The difference between the two conditions may be detectable through an MRI. If there’s evidence of only one episode, you probably have CIS. If images show multiple lesions and evidence of other episodes separated by space and time, you may have MS.
CIS is the result of inflammation and damage to myelin. This can occur anywhere in the CNS.
It’s not exactly clear why this happens. Some risk factors that have been identified include:
- Age. Although you can develop CIS at any age, 70 percent of people diagnosed with it are adults between the ages of 20 and 40 years old.
- Gender. CIS is two to three times more common in women than men. MS is also more common in women than men.
A CIS episode in your past puts you at increased risk of developing MS.
If you have any symptoms of CIS, your primary care physician will probably refer you to a neurologist.
Gathering your complete medical history and having a discussion about your symptoms is the first step. Then, you’ll need a neurological exam, which could include checking your:
- balance and coordination
- eye movements and basic vision
Some diagnostic tests to help find the cause of your symptoms are:
There’s no blood test that can confirm or rule out CIS or MS. However, blood tests play an important role in ruling out other conditions that present with similar symptoms.
An MRI of your brain, neck, and spine is an effective way to detect lesions caused by demyelination. Dye injected into a vein can highlight areas of active inflammation. The contrast dye helps determine if this is your first episode or if you’ve had others.
When you have one symptom of CIS caused by one lesion, it’s called a monofocal episode. If you have several symptoms caused by multiple lesions, you’ve had a multifocal episode.
Lumbar puncture (spinal tap)
After a lumbar puncture, your doctor will analyze your cerebrospinal fluid to look for protein markers. If you have more than the normal amount, it may suggest increased risk of MS.
Evoked potentials measure how your brain responds to sight, sound, or touch. According to a 2013 study,
Conditions to rule out
Before a diagnosis of CIS can be made, all other possible diagnoses must be excluded.
Some of these are:
CIS doesn’t necessarily progress to MS. It may forever remain an isolated event.
According to the National Multiple Sclerosis Society, if your MRI detected MS-like brain lesions, there’s a 60 to 80 percent chance that you’ll have another flare-up and an MS diagnosis within several years.
If the MRI didn’t find MS-like brain lesions, the chance of developing MS within several years is about 20 percent.
According to a
- 48.1 percent of people with CIS transitioned to relapsing-remitting multiple sclerosis (RRMS) within 10 years of their initial episode
- 44.7 percent of people transitioned to RRMS within 20 years
- 14.9 people transitioned to secondary progressive multiple sclerosis (SPMS) within 10 years of their initial episode
- 38.8 percent of people transitioned to SPMS within 20 years
Repeat flare-ups of disease activity is characteristic of MS.
If you have a second episode, your doctor will likely want another MRI. Evidence of multiple lesions separated by time and space points toward a diagnosis of MS.
A mild case of CIS may clear up on its own within a few weeks. It may resolve before you ever get to a diagnosis.
For serious symptoms such as optic neuritis, your doctor might prescribe high-dose steroid treatment. These steroids are given by infusion, but in some cases can be taken orally. Steroids can help you recover from symptoms faster, but they don’t affect your overall outlook.
There are a number of disease-modifying drugs used to treat MS. They’re designed to reduce the frequency and severity of flare-ups. In people with CIS, these medications can be used in the hope of delaying the onset of MS.
The Food and Drug Administration (FDA) has approved the following drugs for the treatment of CIS:
- dimethyl fumarate (Tecfidera)
- diroximel fumarate (Vumerity)
- fingolimod (Gilenya)
- glatiramer acetate (Copaxone, Glatopa)
- interferon beta-1a (Avonex, Rebif)
- interferon beta-1b (Betaseron, Extavia)
- monomethyl fumarate (Bafiertam)
- natalizumab (Tysabri)
- ocrelizumab (Ocrevus)
- ofatumumab (Kesimpta)
- ozanimod (Zeposia)
- peginterferon beta-1a (Plegridy)
- siponimod (Mayzent)
- teriflunomide (Aubagio)
Ask your neurologist about the potential benefits and risks of each before choosing to take one of these powerful medications.
With CIS, there’s no way to know for sure if you’ll eventually develop MS. You may never have another episode.
However, if it appears that you’re at high risk of developing MS, you have a lot to consider.
The next step is to consult with a neurologist experienced in treating CIS and MS. Before making treatment decisions, it might be wise to seek a second opinion.
Whether you choose to take MS drugs or not, be sure to notify your doctor at the first sign of another episode.
MS affects everyone differently. It’s impossible to predict one person’s long-term outlook. After 15 to 20 years,